Thursday February 21, 2019
Home Lead Story OnePlus 6 Red...

OnePlus 6 Red Edition Officially Launched For Rs 39,999 in India

The handset is powered by Qualcomm's flagship Snapdragon 845 chip and runs on OnePlus's customised version of Android "OxygenOS" which is based on Android 8.1 Oreo OS

0
//
OnePlus
The Shenzhen-based smartphone company was set to launch the handset at an event in India on Tuesday. (IANS)

China-based smartphone manufacturer OnePlus on Monday unveiled the “red edition” of its latest flagship OnePlus 6 with 8GB RAM and 128GB internal storage for Rs 39,999.

The new variant of OnePlus 6 would be available for purchase from July 16, the company said in a statement.

“We worked to avoid an overly bright red color while still capturing a sense of self-confidence and positivity,” said Pete Lau, Founder, OnePlus.

The smartphone was launched earlier in May for Rs 34,999 for the 6GB RAM+64GB internal storage and Rs 39,999 for the 8GB RAM+128GB internal storage variant.

Also Read: OnePlus Updates ‘OnePlus Switch’ With Bug-Fixes And More

The device comes with a flagship processor, retaining the company’s proprietary “Dash Charge” that fuels the 3,300 mAh battery from zero to 100 per cent in around 80 minutes, along with a 6.28-inch AMOLED display, dual 16MP + 20MP primary camera, 16MP selfie camera and the display cutting “notch.”

The handset is powered by Qualcomm’s flagship Snapdragon 845 chip and runs on OnePlus’s customised version of Android “OxygenOS” which is based on Android 8.1 Oreo OS.

The company earlier released the “midnight black” colour variant of the smartphone late in June with 8GB RAM and 256GB internal storage priced at Rs 43,999. (IANS)

Next Story

HPV Vaccination May Bring An End To Cervical Cancer In India by 2070

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

0
cancer
Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations. Pixabay

Human papillomavirus (HPV) screening and vaccination must be taken up on a war footing in countries like India to prevent 15 million cervical cancer deaths among women by 2050, a Lancet research said.

Causing the second-highest number of deaths among Indian women among cancer variants, cervical cancer, in a majority of cases, is caused by HPV, a group of more than 150 viruses.

The efforts might even result in cervical cancer being eliminated as a public health hazard in India by 2070-79, according to the study, published in The Lancet Oncology journal.

Combining high uptake of the HPV vaccine and cervical screening could eliminate cervical cancer as a public health hazard in 149 out of 181 countries by 2100 and up to 13 million cases of cervical cancer by 2050.

Cancer
“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS. Pixabay

If the high coverage of HPV vaccination and cervical screening cannot be achieved globally, over 44 million women could be diagnosed with cervical cancer in the next 50 years with two-thirds of these cases and an additional estimated 15 million deaths, would occur in countries with low and medium levels of development.

“More than two thirds of cases prevented would be in countries with low and medium levels of human development like India, Nigeria, and Malawi, where there has so far been limited access to HPV vaccination or cervical screening,” said lead author Professor Karen Canfell from the Cancer Council New South Wales in Australia.

However, large disparities exist in cervical screening and HPV vaccination coverage among countries.

“Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge,” Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS.

“While societal barriers prevent women from seeking medical help in advance, women are forced to come out at a later stage when the disease has reached an advanced stage,” she said.

cancer
Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said. Pixabay

However, Canfell says that despite the enormity of the problem, their findings suggest that “global elimination is within reach with tools that are already available, provided that both high coverage of HPV vaccination and cervical screening can be achieved.

Cervical cancer is the fourth-most common cancer among women, with an estimated 570,000 new cases diagnosed worldwide in 2018, of which around 85 per cent occur in less developed nations.

Screening and broad-spectrum HPV vaccines could potentially prevent up to 84-90 per cent of cervical cancers, the study said.

Also Read: Indian IT Act Silent On Social Media’s Manipulative Role
“Diagnostic tests such as the pap smear are effective in identifying cancerous tendencies.

“However, these tests are available with a limited number of providers and largely within the cities. This makes screening sporadic and leaves out women who live in rural areas,” Aneja added. (IANS)